Boston Partners’s Versigent PLC VGNT Stock Holding History

Boston Partners’s Portfolio VGNT Stock Details VGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-62,714	Closed	-$1.76M	–	864
2026 Q1	$1.76M	Buy	+62,714	New	+$1.95M	﹤0.01%	588

Other funds holding VGNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Boston Partners's VGNT Position: Q2 2026 in Review

Boston Partners sold out of Versigent PLC (VGNT) in Q2 2026, closing a stake of 62,714 shares — an estimated $1.76M sold.

Boston Partners first reported a position in VGNT in Q1 2026 and held it in 1 quarter. The position peaked at $1.76M in Q1 2026. 434 funds tracked by Wall St. Rank hold VGNT as of Q2 2026.

Boston Partners reported no remaining Versigent PLC position as of Q2 2026 after selling out during the quarter.
Boston Partners sold 62,714 Versigent PLC shares in Q2 2026, an estimated $1.76M.
Boston Partners first reported a position in Versigent PLC in Q1 2026 and held it in 1 quarter.
Boston Partners's Versigent PLC position peaked at $1.76M in Q1 2026.
434 funds tracked by Wall St. Rank held Versigent PLC as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.